Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein.
PDF (1.3M)
Journal: 1995/May - Annals of Surgery
ISSN: 0003-4932
PUBMED: 7726676
Abstract:
OBJECTIVE
This study was conducted to determine the role of gut-derived bacteria/endotoxin in the pathogenesis of the multiple-organ damage and mortality, the possible beneficial effect of recombinant bactericidal/permeability-increasing protein (rBPl21), and whether neutralizing endotoxemia by rBPl21 treatment influences tumor necrosis factor (TNF) formation in rats after hemorrhagic shock and resuscitation.
BACKGROUND
Hypovolemic shock might be associated with bacterial or endotoxin translocation as well as systemic sepsis. Similar to bactericidal/permeability-increasing (BPl) protein, rBPl21 has been found to bind endotoxin and inhibit TNF production.
METHODS
A rat model of prolonged hemorrhagic shock (30 to 35 mm Hg for 180 min) followed by adequate resuscitation was employed. Recombinant bactericidal/permeability-increasing protein was administered at 5 mg/kg intravenously. The control group was treated similarly to the BPl group, but received thaumatin as a protein-control preparation in the same dose as rBPl21.
RESULTS
Immediately after resuscitation (230 min), plasma endotoxin levels in the control group (61.0 +/- 16.3 pg/mL) were almost neutralized by rBPl21 treatment (13.8 +/- 4.8 pg/mL, p < 0.05). Plasma TNF levels were not significantly influenced by rBPl21 treatment. The 48-hour survival rate was 68.8% in the treatment group versus 37.5% in the control group (p = 0.08). Microscopic histopathologic examination revealed relatively minor damage to various organs in the treatment group.
CONCLUSIONS
These data suggest that hemorrhagic shock may lead to bacterial/endotoxin translocation with concomitant TNF formation, endogenous endotoxemia may play an important role in the pathogenesis of multiple-organ failure after shock and trauma, TNF formation at an early stage might be related mainly to mechanisms other than Kupffer's cells activation via lipopolysaccharide, and rBPl21 might be a useful therapeutic agent against endogenous bacteria/endotoxin related disorders in severe hemorrhagic shock.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(9)
References
(37)
Diseases
(1)
Conditions
(1)
Chemicals
(7)
Organisms
(4)
Processes
(2)
Similar articles
Articles by the same authors
Discussion board
Ann Surg 221(4): 398-405
PMID: 7726676

Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein.

Abstract

OBJECTIVES: This study was conducted to determine the role of gut-derived bacteria/endotoxin in the pathogenesis of the multiple-organ damage and mortality, the possible beneficial effect of recombinant bactericidal/permeability-increasing protein (rBPl21), and whether neutralizing endotoxemia by rBPl21 treatment influences tumor necrosis factor (TNF) formation in rats after hemorrhagic shock and resuscitation. SUMMARY BACKGROUND DATA: Hypovolemic shock might be associated with bacterial or endotoxin translocation as well as systemic sepsis. Similar to bactericidal/permeability-increasing (BPl) protein, rBPl21 has been found to bind endotoxin and inhibit TNF production. METHODS: A rat model of prolonged hemorrhagic shock (30 to 35 mm Hg for 180 min) followed by adequate resuscitation was employed. Recombinant bactericidal/permeability-increasing protein was administered at 5 mg/kg intravenously. The control group was treated similarly to the BPl group, but received thaumatin as a protein-control preparation in the same dose as rBPl21. RESULTS: Immediately after resuscitation (230 min), plasma endotoxin levels in the control group (61.0 +/- 16.3 pg/mL) were almost neutralized by rBPl21 treatment (13.8 +/- 4.8 pg/mL, p < 0.05). Plasma TNF levels were not significantly influenced by rBPl21 treatment. The 48-hour survival rate was 68.8% in the treatment group versus 37.5% in the control group (p = 0.08). Microscopic histopathologic examination revealed relatively minor damage to various organs in the treatment group. CONCLUSIONS: These data suggest that hemorrhagic shock may lead to bacterial/endotoxin translocation with concomitant TNF formation, endogenous endotoxemia may play an important role in the pathogenesis of multiple-organ failure after shock and trauma, TNF formation at an early stage might be related mainly to mechanisms other than Kupffer's cells activation via lipopolysaccharide, and rBPl21 might be a useful therapeutic agent against endogenous bacteria/endotoxin related disorders in severe hemorrhagic shock.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 398
398
icon of scanned page 399
399
icon of scanned page 400
400
icon of scanned page 401
401
icon of scanned page 402
402
icon of scanned page 403
403
icon of scanned page 404
404
icon of scanned page 405
405

Images in this article

Figure 1.
Figure 1.
on p.399
Figure 2.
Figure 2.
on p.401
Figure 3.
Figure 3.
on p.401
Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med. 1987;38:417–432. [PubMed] [Google Scholar]
  • Rush BF, Jr, Sori AJ, Murphy TF, Smith S, Flanagan JJ, Jr, Machiedo GW. Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis? Ann Surg. 1988 May;207(5):549–554.[PMC free article] [PubMed] [Google Scholar]
  • Koziol JM, Rush BF, Jr, Smith SM, Machiedo GW. Occurrence of bacteremia during and after hemorrhagic shock. J Trauma. 1988 Jan;28(1):10–16. [PubMed] [Google Scholar]
  • Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg. 1990 Mar;125(3):403–404. [PubMed] [Google Scholar]
  • Schlag G, Redl H, Dinges HP, Davies J. Sources of endotoxin in the posttraumatic setting. Prog Clin Biol Res. 1991;367:121–134. [PubMed] [Google Scholar]
  • Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg. 1993 Aug;218(2):111–119.[PMC free article] [PubMed] [Google Scholar]
  • Jiang J, Bahrami S, Leichtfried G, Redl H, Ohlinger W, Schlag G. Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg. 1995 Jan;221(1):100–106.[PMC free article] [PubMed] [Google Scholar]
  • Yao YM, Tian HM, Wang YP, Sheng ZY, Shi ZG, Xu SH. Protective effect of Re-LPS antiserum on experimental multiple system organ failure. Chin Med J (Engl) 1992 Oct;105(10):833–838. [PubMed] [Google Scholar]
  • Yao Y, Tian H, Sheng Z, Wang YP, Shi Z, Lan F. The role of endotoxin in the pathogenesis of experimental multiple system organ failure: a preliminary report. Chin Med Sci J. 1992 Sep;7(3):161–165. [PubMed] [Google Scholar]
  • Weiss J, Olsson I. Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood. 1987 Feb;69(2):652–659. [PubMed] [Google Scholar]
  • Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol. 1990 Jan 15;144(2):662–666. [PubMed] [Google Scholar]
  • Gazzano-Santoro H, Parent JB, Grinna L, Horwitz A, Parsons T, Theofan G, Elsbach P, Weiss J, Conlon PJ. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun. 1992 Nov;60(11):4754–4761.[PMC free article] [PubMed] [Google Scholar]
  • Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, Theofan G. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest. 1992 Sep;90(3):1122–1130.[PMC free article] [PubMed] [Google Scholar]
  • Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. J Immunol. 1993 Oct 15;151(8):4258–4265. [PubMed] [Google Scholar]
  • Mészáros K, Aberle S, Dedrick R, Machovich R, Horwitz A, Birr C, Theofan G, Parent JB. Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein. Blood. 1994 May 1;83(9):2516–2525. [PubMed] [Google Scholar]
  • Kohn FR, Ammons WS, Horwitz A, Grinna L, Theofan G, Weickmann J, Kung AH. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia. J Infect Dis. 1993 Nov;168(5):1307–1310. [PubMed] [Google Scholar]
  • Ammons WS, Kung AH. Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin. Circ Shock. 1993 Nov;41(3):176–184. [PubMed] [Google Scholar]
  • Kelly CJ, Cech AC, Argenteanu M, Gallagher H, Shou J, Minnard E, Daly JM. Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia. Surgery. 1993 Aug;114(2):140–146. [PubMed] [Google Scholar]
  • Vandermeer TJ, Menconi MJ, O'Sullivan BP, Larkin VA, Wang H, Kradin RL, Fink MP. Bactericidal/permeability-increasing protein ameliorates acute lung injury in porcine endotoxemia. J Appl Physiol (1985) 1994 May;76(5):2006–2014. [PubMed] [Google Scholar]
  • von Asmuth EJ, Maessen JG, van der Linden CJ, Buurman WA. Tumour necrosis factor alpha (TNF-alpha) and interleukin 6 in a zymosan-induced shock model. Scand J Immunol. 1990 Oct;32(4):313–319. [PubMed] [Google Scholar]
  • Schlag G, Redl H, van Vuuren CJ, Davies J. Hyperdynamic sepsis in baboons: II. Relation of organ damage to severity of sepsis evaluated by a newly developed morphological scoring system. Circ Shock. 1992 Dec;38(4):253–263. [PubMed] [Google Scholar]
  • Moore FA, Moore EE, Poggetti R, McAnena OJ, Peterson VM, Abernathy CM, Parsons PE. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991 May;31(5):629–638. [PubMed] [Google Scholar]
  • Peitzman AB, Udekwu AO, Ochoa J, Smith S. Bacterial translocation in trauma patients. J Trauma. 1991 Aug;31(8):1083–1087. [PubMed] [Google Scholar]
  • Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine. 1990 May;2(3):170–174. [PubMed] [Google Scholar]
  • Thiemermann C, Szabó C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):267–271.[PMC free article] [PubMed] [Google Scholar]
  • Baker JW, Deitch EA, Li M, Berg RD, Specian RD. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma. 1988 Jul;28(7):896–906. [PubMed] [Google Scholar]
  • Chaudry IH, Ayala A. Mechanism of increased susceptibility to infection following hemorrhage. Am J Surg. 1993 Feb;165(2A):59S–67S. [PubMed] [Google Scholar]
  • Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg. 1990 Dec;212(6):694–700.[PMC free article] [PubMed] [Google Scholar]
  • Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol. 1991 Jan;260(1 Pt 2):R167–R171. [PubMed] [Google Scholar]
  • Rhee P, Waxman K, Clark L, Kaupke CJ, Vaziri ND, Tominaga G, Scannell G. Tumor necrosis factor and monocytes are released during hemorrhagic shock. Resuscitation. 1993 Jun;25(3):249–255. [PubMed] [Google Scholar]
  • Stylianos S, Wakabayashi G, Gelfand JA, Harris BH. Experimental hemorrhage and blunt trauma do not increase circulating tumor necrosis factor. J Trauma. 1991 Aug;31(8):1063–1067. [PubMed] [Google Scholar]
  • Shenkar R, Abraham E. Effects of hemorrhage on cytokine gene transcription. Lymphokine Cytokine Res. 1993 Aug;12(4):237–247. [PubMed] [Google Scholar]
  • Scannell G, Waxman K, Kaml GJ, Ioli G, Gatanaga T, Yamamoto R, Granger GA. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res. 1993 Apr;54(4):281–285. [PubMed] [Google Scholar]
  • Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. [PubMed] [Google Scholar]
  • Caridis DT, Ishiyama M, Woodruff PW, Fine J. Role of the intestinal flora in clearance and detoxification of circulating endotoxin. J Reticuloendothel Soc. 1973 Dec;14(6):513–521. [PubMed] [Google Scholar]
  • Gans H, Matsumoto K. The escape of endotoxin from the intestine. Surg Gynecol Obstet. 1974 Sep;139(3):395–402. [PubMed] [Google Scholar]
  • Deitch EA, Berg R, Specian R. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg. 1987 Feb;122(2):185–190. [PubMed] [Google Scholar]
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria.
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria.
Copyright notice
Abstract
OBJECTIVES: This study was conducted to determine the role of gut-derived bacteria/endotoxin in the pathogenesis of the multiple-organ damage and mortality, the possible beneficial effect of recombinant bactericidal/permeability-increasing protein (rBPl21), and whether neutralizing endotoxemia by rBPl21 treatment influences tumor necrosis factor (TNF) formation in rats after hemorrhagic shock and resuscitation. SUMMARY BACKGROUND DATA: Hypovolemic shock might be associated with bacterial or endotoxin translocation as well as systemic sepsis. Similar to bactericidal/permeability-increasing (BPl) protein, rBPl21 has been found to bind endotoxin and inhibit TNF production. METHODS: A rat model of prolonged hemorrhagic shock (30 to 35 mm Hg for 180 min) followed by adequate resuscitation was employed. Recombinant bactericidal/permeability-increasing protein was administered at 5 mg/kg intravenously. The control group was treated similarly to the BPl group, but received thaumatin as a protein-control preparation in the same dose as rBPl21. RESULTS: Immediately after resuscitation (230 min), plasma endotoxin levels in the control group (61.0 +/- 16.3 pg/mL) were almost neutralized by rBPl21 treatment (13.8 +/- 4.8 pg/mL, p < 0.05). Plasma TNF levels were not significantly influenced by rBPl21 treatment. The 48-hour survival rate was 68.8% in the treatment group versus 37.5% in the control group (p = 0.08). Microscopic histopathologic examination revealed relatively minor damage to various organs in the treatment group. CONCLUSIONS: These data suggest that hemorrhagic shock may lead to bacterial/endotoxin translocation with concomitant TNF formation, endogenous endotoxemia may play an important role in the pathogenesis of multiple-organ failure after shock and trauma, TNF formation at an early stage might be related mainly to mechanisms other than Kupffer's cells activation via lipopolysaccharide, and rBPl21 might be a useful therapeutic agent against endogenous bacteria/endotoxin related disorders in severe hemorrhagic shock.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.